Last Updated:
Name Designation Appointment Date Status
Shubham Santoshkumar Singh

Appointed as Designated Partner since July 2025

 Designated Partner 26-Jul-2025 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Seetaram Indo-Pharma And Intermediate Llp.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Sumit Santoshkumar Singh

Appointed as Designated Partner since July 2025

 Designated Partner 26-Jul-2025 Current
Santoshkumar Singh

Appointed as Designated Partner since July 2025

 Designated Partner 26-Jul-2025 Current

People Timeline

Explore the timeline of key personnel in Seetaram Indo-Pharma And Intermediate Llp's leadership journey.

Contact Details
  • Address Unit No. 125, 2Nd Floor,, A4 Rashtrakuta Building,, Ambarnath Maharashtra, 421505, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 421505
  • Country India
  • Website -
Frequently Asked Questions
You can contact Seetaram Indo-Pharma And Intermediate Llp through their registered address at Unit No. 125, 2Nd Floor,, A4 Rashtrakuta Building,, Ambarnath Maharashtra, 421505, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Seetaram Indo-Pharma And Intermediate Llp are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Shubham Santoshkumar Singh
  • Sumit Santoshkumar Singh
  • Santoshkumar Singh
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available